is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG.
However, there were more steps necessary to maintain a target IOP range with additional glaucoma medications in the medical arm. The SLT/Med study reinforces the potential use of SLT as an option ...
To report the safety and effectiveness of selective laser trabeculoplasty (SLT) using the SLT mode of the VISULAS green laser in patients with primary open-angle glaucoma (POAG). Twelve months results ...
Neovascular glaucoma is a vision-threatening eye condition. It’s characterized by new blood vessel growth over your iris and the area where fluid drains from your eye. Glaucoma is a group of ...
announces another groundbreaking milestone as the first practice in Texas to offer the Voyager Direct Selective Laser Trabeculoplasty (DSLT) system. This state-of-the-art technology represents a ...